Company Filing History:
Years Active: 2016
Title: The Innovative Contributions of Anna-Katharina Wiegers
Introduction
Anna-Katharina Wiegers is a notable inventor based in Nuremberg, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of binding members for the treatment of human cytomegalovirus (hCMV). Her work is crucial in advancing therapeutic options for hCMV infections.
Latest Patents
Anna-Katharina Wiegers holds 1 patent related to her invention of binding members that can neutralize the biological effects of hCMV. This invention is particularly important for the treatment and prophylaxis of hCMV infection, showcasing her innovative approach to addressing viral challenges.
Career Highlights
Currently, Anna-Katharina Wiegers is associated with 4-Antibody AG, a company focused on developing antibody-based therapies. Her role in this organization highlights her commitment to advancing medical science through innovative research and development.
Collaborations
Throughout her career, Anna-Katharina has collaborated with esteemed colleagues such as Ulf Grawunder and Michael Mach. These partnerships have further enriched her research and contributed to the success of her projects.
Conclusion
Anna-Katharina Wiegers exemplifies the spirit of innovation in biotechnology. Her work on binding members for hCMV treatment is a testament to her dedication to improving health outcomes through scientific advancements.